IL17A and type 2 diabetes mellitus: Moreover, IL-17 suppresses fibrosis via the STAT-3 and WAP domain protein pathways in models of T1D and T2D, and tubulointerstitial fibrosis can be rescued by suppressing intrarenal IL-17A1 CD41 T cells (41, 44).